We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak -- United States, May 22-October 21, 2022.
- Authors
Duffy, Jonathan; Marquez, Paige; Moro, Pedro; Weintraub, Eric; Yon Yu; Boersma, Peter; Donahue, James G.; Glanz, Jason M.; Goddard, Kristin; Hambidge, Simon J.; Lewin, Bruno; Lewis, Ned; Rouse, Douglas; Shimabukuro, Tom
- Abstract
The article focuses on safety monitoring of JYNNEOS is a nonreplicating viral vaccine licensed for prevention of smallpox. It mentions Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for administration of doses by intradermal injection for adults aged ≥18 years as a strategy to increase vaccine supply. It also mentions Centers for Disease Control & Prevention (CDC) has monitored JYNNEOS vaccine safety using the Vaccine Adverse Event Reporting System (VAERS).
- Subjects
VIRAL vaccines; PREVENTION of smallpox; UNITED States. Food &; Drug Administration; INTRADERMAL injections; CENTERS for Disease Control &; Prevention (U.S.); ADVERSE health care events
- Publication
MMWR: Morbidity & Mortality Weekly Report, 2022, Vol 71, Issue 49, p1555
- ISSN
0149-2195
- Publication type
Article
- DOI
10.15585/mmwr.mm7149a4